2 Nov 2022
Trends in Point of Care Diagnostics and Continuous Monitoring
IDTechEx Reflects on Trends in 2022.
For the past decade, the healthcare industry has looked towards decentralization as a means of relieving the pressure placed on healthcare systems.
23 Aug 2022
Partnered to provide a wearable device and app as part of a clinical study looking into the effectiveness of VNS Therapy in patients with difficult-to-treat depression.
30 Mar 2021
Non-Invasive Glucose Sensing Technologies
In this premium article, IDTechEx examines various approaches that have been made in developing non-invasive glucose sensors for diabetes management.
15 Feb 2019
Johnson & Johnson $3.4 billion in cash for Auris surgical robots
Johnson & Johnson announced that Ethicon Inc entered into a definitive agreement to acquire Auris Health Inc for approximately $3.4 billion in cash.
4 Dec 2018
Low cost technology to print sensors enabling smart contact lenses
VSPARTICLE announced its low-cost technology to print nanostructured materials that will finally enable applications such as smart contact lenses to succeed. The nanotech company has developed an additive manufacturing technology that can be used for numerous applications, such as producing real-time medical sensors (glucose sensing, bio-marker sensing, etc.), as well as, accurate gas sensors.
26 Oct 2017
NASCAR, JCDecaux, Galvani and Terrafugia to open the IDTechEx Show!
Opening the IDTechEx Show! in Santa Clara, Nov 15-16, are four select Cornerstone presentations which will showcase how new technologies are coming to market which solve big problems created by changing demographics and global megatrends, from mobility to healthcare to enabling the ubiquity of electronics.
8 Sep 2017
Implantable devices to alter electrical impulses in the body
GSK has announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines.
6 Feb 2017
How Big Pharma is betting on electronics
As the business model for commercializing new drugs becomes increasingly more difficult to sustain, the pharmaceutical industry is trying to reinvent itself. One bet is on electronic devices that could provide direct treatment of some chronic diseases. The race is on to find new materials that will be compatible for this new form of medicine.
Full profile interview
17 Mar 2016
Google - Verily
Dr Harry Zervos spoke to Sohyun Park, a hardware engineer with Verily, previously a division of Google X and now Alphabet's research organization that focuses on developing new technologies in life sciences.Sohyun discussed with Dr Zervos some of Verily's activities in smart contact lenses and smart glasses platform developments.